BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17697940)

  • 1. Cellular prion protein protects against reactive-oxygen-species-induced DNA damage.
    Watt NT; Routledge MN; Wild CP; Hooper NM
    Free Radic Biol Med; 2007 Sep; 43(6):959-67. PubMed ID: 17697940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species-mediated beta-cleavage of the prion protein in the cellular response to oxidative stress.
    Watt NT; Taylor DR; Gillott A; Thomas DA; Perera WS; Hooper NM
    J Biol Chem; 2005 Oct; 280(43):35914-21. PubMed ID: 16120605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
    Kumar R; McClain D; Young R; Carlson GA
    J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
    Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
    PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
    Norstrom EM; Mastrianni JA
    J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein protects mice from lethal infection with influenza A viruses.
    Chida J; Hara H; Yano M; Uchiyama K; Das NR; Takahashi E; Miyata H; Tomioka Y; Ito T; Kido H; Sakaguchi S
    PLoS Pathog; 2018 May; 14(5):e1007049. PubMed ID: 29723291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion metal interaction: is prion pathogenesis a cause or a consequence of metal imbalance?
    Rana A; Gnaneswari D; Bansal S; Kundu B
    Chem Biol Interact; 2009 Oct; 181(3):282-91. PubMed ID: 19660443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal cellular prion protein protects against manganese-induced oxidative stress and apoptotic cell death.
    Choi CJ; Anantharam V; Saetveit NJ; Houk RS; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2007 Aug; 98(2):495-509. PubMed ID: 17483122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein.
    Sakudo A; Ikuta K
    Protein Pept Lett; 2009; 16(3):217-29. PubMed ID: 19275734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding and misfolding of the prion protein in the secretory pathway.
    Tatzelt J; Winklhofer KF
    Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
    Prasad KN; Bondy SC
    Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
    Bate C; Tayebi M; Diomede L; Salmona M; Williams A
    BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between prion proteins and Aβ₁₋₄₂ oligomers in cytotoxicity and apoptosis.
    Hyeon JW; Kim SY; Park JS; Choi BY; Lee SM; Ju YR; An SS; Kim CK
    Biochem Biophys Res Commun; 2012 Jul; 424(2):214-20. PubMed ID: 22743555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of antioxidant defense in mice lacking cellular prion protein.
    Klamt F; Dal-Pizzol F; Conte da Frota ML; Walz R; Andrades ME; da Silva EG; Brentani RR; Izquierdo I; Fonseca Moreira JC
    Free Radic Biol Med; 2001 May; 30(10):1137-44. PubMed ID: 11369504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A receptor for infectious and cellular prion protein.
    Martins VR
    Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells.
    Karpuj MV; Giles K; Gelibter-Niv S; Scott MR; Lingappa VR; Szoka FC; Peretz D; Denetclaw W; Prusiner SB
    Mol Med; 2007; 13(3-4):190-8. PubMed ID: 17592554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional links between prion protein and copper.
    Varela-Nallar L; Toledo EM; Chacón MA; Inestrosa NC
    Biol Res; 2006; 39(1):39-44. PubMed ID: 16629163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Singlet oxygen-mediated damage to cellular DNA determined by the comet assay associated with DNA repair enzymes.
    Ravanat JL; Sauvaigo S; Caillat S; Martinez GR; Medeiros MH; Di Mascio P; Favier A; Cadet J
    Biol Chem; 2004 Jan; 385(1):17-20. PubMed ID: 14977042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
    Rigter A; Bossers A
    J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
    Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
    PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.